Gonadal sex hormones may account for the sexual dimorphism in the immu
ne response and for the greater incidence of autoimmune disease in fem
ales. We have previously reported the presence of progesterone (P) def
iciency in female patients with thyroid and ovarian autoimmune disease
. In this context, the hormonal profile in 9 women with rheumatoid art
hritis (RA) and in 9 age-matched ealthy women, were evaluated to verif
y the presence of a steroid hormone secretion impairment in a systemic
autoimmune disease, further supporting our hypothesis of P deficiency
involvement. P and androgen plasma levels, in the luteal phase, were
significantly lower (p<0.05 and 0.005, respectively) in RA patients th
an in the control group, with a consequent decrease of the free androg
en index. Moreover, despite normal cortisol values, corticosterone (B)
plasma levels were significantly higher in the RA patients (p<0.01 an
d 0.05 in follicular and luteal phase, respectively). Therefore, our p
resent data confirm the androgen deficiency in patients with a systemi
c autoimmune disease, such as RA and support the immunomodulator effec
t of P. Finally, the higher B plasma levels in RA patients may suggest
the presence of a slight impairment of the immune hypothalamic-pituit
ary-adrenal axis (HPAA), supporting its role in certain phases of RA p
athogenesis. In conclusion, in addition to androgens, the immunomodula
tor role of P should also be taken into account in the pathogenesis of
the systemic autoimmune disease.